Real-World Use of Sotrovimab for Pre-Emptive Treatment in High-Risk Hospitalized COVID-19 Patients: An Observational Cross-Sectional Study.

Ong, Sean W X; Ren, Dongdong; Lee, Pei Hua; Sutjipto, Stephanie; Dugan, Christopher; Khoo, Bo Yan; Tay, Jun Xin; Vasoo, Shawn; Young, Barnaby E; Lye, David C

Ong, Sean W X; Ren, Dongdong; Lee, Pei Hua; Sutjipto, Stephanie; Dugan, Christopher; Khoo, Bo Yan; Tay, Jun Xin; Vasoo, Shawn; Young, Barnaby E; Lye, David C.

Afiliação

Ong SWX; National Centre for Infectious Diseases, 16 Jln Tan Tock Seng, Singapore 308442, Singapore.
Ren D; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore 308433, Singapore.
Lee PH; National Centre for Infectious Diseases, 16 Jln Tan Tock Seng, Singapore 308442, Singapore.
Sutjipto S; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore 308433, Singapore.
Dugan C; National Centre for Infectious Diseases, 16 Jln Tan Tock Seng, Singapore 308442, Singapore.
Khoo BY; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore 308433, Singapore.
Tay JX; National Centre for Infectious Diseases, 16 Jln Tan Tock Seng, Singapore 308442, Singapore.
Vasoo S; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore 308433, Singapore.
Young BE; National Centre for Infectious Diseases, 16 Jln Tan Tock Seng, Singapore 308442, Singapore.
Lye DC; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore 308433, Singapore.

Antibiotics (Basel) ; 11(3)2022 Mar 05.

Article em En | MEDLINE | ID: mdl-35326808

Palavras-chave

COVID-19; SARS-CoV-2; monoclonal antibody; sotrovimab; treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Antibiotics (Basel) Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google